COMP <GO>
EWTX vs DNTH // GROSS PROFIT MARGIN
Edgewise Therapeutics Inc. (NASDAQ) VS. Dianthus Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: EWTX 4
— DNTH 6
■ METRIC PARITY
LAST: $38.11 (-2.03%) • MKT CAP: $4.22B
gross-margins
—
LAST: $82.25 (-0.16%) • MKT CAP: $4.61B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EWTX VS. DNTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EWTX | DNTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.90% | -30.70% | -1.20 | DNTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.41% | -2.79% | -0.62 | DNTH | /fcf-yield <GO> |
| Operating Margin | -16.20% | -60.00% | +43.80 | EWTX | /operating-margins <GO> |
| Net Profit Margin | 0.00% | -60.00% | +60.00 | EWTX | /net-margins <GO> |
| Revenue Growth (YoY) | -1.10% | -65.00% | +63.90 | EWTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 26.00 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | DNTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 46.8 | -1.10 | DNTH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 1.08 | +0.02 | EWTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | 20.0x | +5.00 | DNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.22B | $4.61B | -$383.2M | DNTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EWTX REV | DNTH REV | EWTX GROSS % | DNTH GROSS % | EWTX FCF | DNTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $535.9M | $2.0M | — | — | -$144.1M | -$129.2M |
| FY 2024 | $444.7M | $6.2M | — | — | -$110.3M | -$78.5M |
| FY 2023 | $320.2M | $2.8M | — | — | -$91.9M | -$37.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EWTX // BETA 1.10
DNTH // BETA 1.08